.NeuroRestore
Is a research, innovation and treatment center that develops and applies bioengineering strategies involving neurosurgical interventions to restore neurological functions.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $1.1m | Grant | |
| Total Funding | 000k | ||
Related Content
NeuroRestore is a pioneering research, innovation, and treatment center specializing in the development and application of bioengineering strategies to restore neurological functions. The company focuses on integrating implantable neurotechnologies and innovative treatments, which have been rigorously tested over the past 15 years in preclinical studies involving rodent and non-human primate models. NeuroRestore's core mission is to address severe neurological conditions such as paraplegia, tetraplegia, Parkinson's disease, stroke, and traumatic brain injuries through advanced neurosurgical interventions.
Operating in the healthcare and medical research market, NeuroRestore serves patients suffering from debilitating neurological conditions. The business model revolves around the development and clinical application of cutting-edge neurotechnologies, which are designed to improve the quality of life for patients by restoring lost neurological functions. Revenue is generated through a combination of research grants, clinical services, and partnerships with medical institutions and technology companies.
NeuroRestore's commitment to innovation and rigorous scientific validation sets it apart in the field of neurological rehabilitation. By leveraging advanced bioengineering techniques, the company aims to make significant strides in the treatment of complex neurological disorders.
Keywords: neurosurgical interventions, bioengineering, neurological functions, implantable neurotechnologies, paraplegia, tetraplegia, Parkinson's disease, stroke, traumatic brain injuries, medical research.